Prelude Therapeutics Incorporated
NASDAQ:PRLD
1.03 (USD) • At close June 6, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 4 | 3 | 0 | 0 | 3.424 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 0 | 0 | 0.452 | 0.426 | 0.331 | 0.279 | 0.723 | 0.71 | 0.799 | 0.776 | 0.749 | 0.718 | 0.69 | 0.622 | 0.489 | 0.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 0 | 3.511 | 3 | -0.452 | -0.426 | 3.093 | -0.279 | -0.723 | -0.71 | -0.799 | -0.776 | -0.749 | -0.718 | -0.69 | -0.622 | -0.489 | -0.442 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0.878 | 1 | 0 | 0 | 0.903 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 28.816 | 31.62 | 29.457 | 29.509 | 27.409 | 30.332 | 26.261 | 24.966 | 21.834 | 25.869 | 22.889 | 21.31 | 22.821 | 25.178 | 22.721 | 22.409 | 16.47 | 14.572 | 15.293 | 9.776 | 8.536 | 8.849 | 5.49 | 4.97 | 4.97 |
| Algemene en administratieve kosten
| 5.79 | 6.211 | 7.919 | 7.655 | 6.934 | 7.047 | 7.124 | 7.432 | 7.281 | 7.516 | 7.517 | 8.151 | 7.467 | 7.832 | 8.115 | 5.513 | 5.497 | 4.874 | 2.851 | 1.66 | 1.201 | 1.246 | 1.394 | 0.595 | 0.595 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | -0.452 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 5.79 | 6.211 | 7.919 | 7.203 | 6.934 | 7.047 | 7.124 | 7.432 | 7.281 | 7.516 | 7.517 | 8.151 | 7.467 | 7.832 | 8.115 | 5.513 | 5.497 | 4.874 | 2.851 | 1.66 | 1.201 | 1.246 | 1.394 | 0.595 | 0.595 |
| Overige kosten
| 0 | 0 | 0 | 2.424 | 2.912 | 4.304 | 2.777 | 1.967 | 1.397 | 4.744 | 0.448 | 2.087 | 0.823 | 0.168 | 0.149 | 1.057 | 0.667 | 0.196 | 1.384 | 0.028 | 0.226 | 0.056 | 0.15 | 0 | 0 |
| Bedrijfskosten
| 34.606 | 37.831 | 37.376 | 36.712 | 34.343 | 37.379 | 33.385 | 32.398 | 29.115 | 33.385 | 30.406 | 29.461 | 30.288 | 33.01 | 30.836 | 27.922 | 21.967 | 19.446 | 18.144 | 11.436 | 9.737 | 10.095 | 6.884 | 5.399 | 5.399 |
| Bedrijfsresultaat
| -34.606 | -33.831 | -34.376 | -37.164 | -34.343 | -37.379 | -33.385 | -32.398 | -29.115 | -33.385 | -30.406 | -29.461 | -30.288 | -33.01 | -30.836 | -27.922 | -21.967 | -19.446 | -18.144 | -11.436 | -9.737 | -10.095 | -6.884 | -5.565 | -5.565 |
| Bedrijfsresultaat ratio
| 0 | -8.458 | -11.459 | 0 | 0 | -10.917 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 2.521 | 5.1 | 2.105 | 2.424 | 2.912 | 4.304 | 2.777 | 1.967 | 1.397 | 4.744 | 0.448 | 2.087 | 0.823 | 0.168 | 0.149 | 1.057 | 0.667 | 0.196 | 1.384 | 0.028 | 0.226 | 0.056 | 0.15 | 0.167 | 0.167 |
| Inkomen voor belasting
| -32.085 | -28.731 | -32.271 | -34.74 | -31.431 | -33.075 | -30.608 | -30.431 | -27.718 | -28.641 | -29.958 | -27.374 | -29.465 | -32.842 | -30.687 | -26.865 | -21.3 | -19.25 | -16.76 | -11.408 | -9.511 | -10.039 | -6.734 | -5.399 | -5.399 |
| Inkomen voor belasting ratio
| 0 | -7.183 | -10.757 | 0 | 0 | -9.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0 | 0 | 0 | -0.426 | 1.676 | -0.279 | 0.239 | -1.397 | -7.654 | -0.448 | -2.087 | -0.823 | -0.168 | -0.356 | -0.29 | -0.282 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nettowinst
| -32.085 | -28.731 | -32.271 | -34.74 | -31.431 | -33.075 | -30.608 | -30.431 | -26.321 | -20.987 | -29.51 | -25.287 | -28.642 | -32.842 | -30.687 | -26.865 | -21.3 | -19.25 | -16.76 | -11.408 | -9.511 | -10.039 | -6.734 | -5.399 | -5.399 |
| Nettowinstmarge
| 0 | -7.183 | -10.757 | 0 | 0 | -9.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.42 | -0.38 | -0.43 | -0.46 | -0.42 | -0.48 | -0.45 | -0.54 | -0.55 | -0.44 | -0.62 | -0.53 | -0.61 | -0.71 | -0.66 | -0.58 | -0.47 | -0.51 | -0.44 | -0.3 | -0.29 | -0.31 | -0.21 | -3.43 | -3.43 |
| Verwaterde WPA
| -0.42 | -0.38 | -0.43 | -0.46 | -0.42 | -0.48 | -0.45 | -0.54 | -0.55 | -0.44 | -0.62 | -0.53 | -0.61 | -0.71 | -0.66 | -0.58 | -0.47 | -0.51 | -0.44 | -0.3 | -0.29 | -0.31 | -0.21 | -3.42 | -3.42 |
| EBITDA
| -34.171 | -33.342 | -33.971 | -36.712 | -33.917 | -37.048 | -33.106 | -32.117 | -28.837 | -33.023 | -30.069 | -29.143 | -29.981 | -32.72 | -30.57 | -27.723 | -21.807 | -19.313 | -18.002 | -11.301 | -9.605 | -9.967 | -6.785 | -5.488 | -5.488 |
| EBITDA ratio
| 0 | -8.336 | -11.324 | 0 | 0 | -10.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |